EurekaMag
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy


Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy



Leukemia and Lymphoma 53(6): 1057-1061



ISSN/ISBN: 1042-8194

PMID: 22149167

DOI: 10.3109/10428194.2011.644548

An international myeloma meeting entitled "Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy" was held in Freiburg, Germany in July 2011 to discuss novel insights into and approaches to myeloma bone disease and other bone-seeking tumors. This review briefly summarizes the most prominent data of the meeting and current literature on our understanding of bone disease, the role of imaging techniques, operative interventions and systemic bone-seeking treatment, all of which should further improve our future therapeutic choices.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052004188

Download citation: RISBibTeXText

Related references

Challenging the current approaches to multiple myeloma-related bone disease: from bisphosphonates to target Therapy. Current Cancer Drug Targets 9(7): 854-870, 2009

Current approaches in multiple myeloma and other cancer-related bone diseases. Deutsche Medizinische Wochenschrift 137(20): 1057-1061, 2012

Basic Approaches in Therapy of Multiple Sclerosis (MS) and Related Diseases: Current Achievement and Prospective. Central Nervous System Agents in Medicinal Chemistry 18(1): 21-31, 2018

Basic Approaches in Therapy of Multiple Sclerosis (MS) and Related Diseases: Current Achievement and Prospective. Central Nervous System Agents in Medicinal Chemistry 18(1): 21-31, 2018

Targeted Approaches to Inhibit Sialylation of Multiple Myeloma in the Bone Marrow Microenvironment. Frontiers in Bioengineering and Biotechnology 7: 252, 2019

Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(3): 1218-1225, 1998

Bone targeted radioisotope therapy for treatment of multiple myeloma and bone tumors. International Journal of Cancer Suppl (13): 104, 2002

The clinical and cost considerations of bisphosphonates in preventing bone complications in patients with metastatic breast cancer or multiple myeloma. Drugs 61(9): 1253-1274, 2001

Bone metastases and non-small cell lung cancer: from bisphosphonates to targeted therapy. Current Medicinal Chemistry 19(32): 5524-5535, 2012

Multiple myeloma and bone disease: pathogenesis and current therapeutic approaches. Hippokratia 14(2): 76-81, 2010

Current and future approaches to therapy for multiple myeloma. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(1): 9-15, 1995

Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates. American Journal of Hematology 94(4): 400-407, 2019

Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial. Blood 119(23): 5374-5383, 2012

One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost-benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ). Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 30(9): 7047-7051, 2022

Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 41(3): 222-228, 2012